Hachung Chung’s curiosity about the immune system is now leading her to delve into a longstanding question: Why is the brain so prone to inflammation in the absence of pathogens?
Sebastián Riquelme is one of the pioneers in the growing field of immunometabolism, investigating how the processes that turn food into energy impact the outcome of infectious diseases.
The coming COVID boosters aren't the only vaccines adults should consider. Now's a good time for people over 18 to make sure they're up to date with flu, tetanus, and other routine vaccines.
Cancer patients on active treatment are 35% less likely to develop COVID-19 than patients not receiving treatment, though those who did test positive for SARS-CoV-2 experienced higher death rates.
Prioritizing older New Yorkers for COVID vaccines and delaying second doses could reduce hospitalizations and deaths, according to new modeling projections from Mailman epidemiologists.
Millions more Americans will be infected with SARS-CoV-2 and become ill with COVID-19 if policies to enforce physical distancing are lifted prematurely, Mailman epidemiologists say.
Mailman experts and other policymakers discuss measures that should be deployed during vaccine rollout to reduce inequities, already worsened by the pandemic, in the U.S. and globally.
Columbia University bioethicist Maya Sabatello says a Truth and Reconciliation Commission is needed to confront the structural racism in health care (and society) highlighted by the COVID-19 pandemic.
Cancer patients are especially vulnerable to COVID and would benefit from the protection the vaccine offers, says Gary Schwartz, MD, deputy director of the Herbert Irving Comprehensive Cancer Center.
A strategic decision-making and team-building exercise for hospital executives—developed at Columbia University Mailman School of Public Health—now includes a simulated pandemic.
Viral load, the amount of virus detected in a PCR nasal swab, can be used to predict patient outcomes and guide quarantine decisions, Daniel Griffin says.